Brian Duncan, MD
Orthopaedic Surgery · Atchison, KSNPI 1225188873
Payments from drug & device makers
Across 66 payments — averaging $61.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$3K
- Stryker$433
- Smith+Nephew$217
- Conformis, Inc.$116
- Pfizer$26
- Radius Health, Inc.$26
- plus $272 from 16 others
What the payments were for
- Travel & lodging$2,46860%
- Food & beverage$1,61740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 35 | $2,996 |
| Stryker | 7 | $433 |
| Smith+Nephew | 3 | $217 |
| Conformis, Inc. | 1 | $116 |
| Pfizer | 2 | $26 |
| Radius Health, Inc. | 2 | $26 |
| Titan Surgical Group, LLC | 1 | $23 |
| Bioventus LLC | 1 | $23 |
| ERMI LLC | 1 | $22 |
| Convatec Inc. | 1 | $21 |
| Acumed LLC | 1 | $21 |
| AbbVie | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Organogenesis Inc. | 1 | $17 |
| Acelrx Pharmaceuticals, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Pacira Therapeutics, Inc. | 1 | $14 |
| Baudax Bio Inc. | 1 | $13 |
| GSK | 1 | $13 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$1,844
- Avenir$343
- Regeneten$146
- MAKO$129
- Actera Hip Stem$116
- iTotal Hip Replacement System$116
How this compares
$4,085 in reported general payments places this provider in the 50th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 20 | $147 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $92 |
| Tramadol Hcl | 22 | $84 |
| Oxycodone Hcl | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Atchison
- Daniel ProhaskaWichita$1.3M
- James McAteeManhattan$641K
- Jeffrey RandallLawrence$623K
- Brian IpsenGalena$572K
- David AndersonKansas City$490K
- Brandon CarlsonKansas City$299K
- Jacob DeisterTopeka$185K
- Harold EllsworthLeawood$154K
- Tyler BronWichita$107K
- William ReedLenexa$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.